Actinomycin-D for methotrexate-resistant low-risk gestational trophoblastic neoplasia (GTN)

被引：0
|
作者：
Lurain, J. [1 ]
Schink, J. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Prentice Womens Hosp, Chicago, IL 60611 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [2] Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
    Maesta, Izildinha
    Nitecki, Roni
    Freitas Desmarais, Cecilia Canedo
    Horowitz, Neil S.
    Goldstein, Donald P.
    Elias, Kevin M.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 372 - 378
  • [3] Actinomycin D for Methotrexate-Failed Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Chapman-Davis, Eloise
    Hoekstra, Anna V.
    Schink, Julian C.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (7-8) : 283 - 287
  • [4] Outcome of low-risk gestational trophoblastic neoplasia (GTN) treated with methotrexate
    Ahmeed, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 202 - 202
  • [5] OUTCOME OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN) TREATED WITH METHOTREXATE
    Alobaid, A.
    Ahmeed, S.
    Saleh, R.
    Mattar, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [6] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply
    You, Benoit
    Bolze, Pierre-Adrien
    Golfier, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4350 - +
  • [7] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
  • [8] Can carboplatin or etoposide replace actinomycin-D for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
    Ribeiro Mora, Paulo Alexandre
    Sun, Sue Yazaki
    Velarde, Guillermo Coca
    Rezende Filho, Jorge
    Uberti, Elza H.
    Vieira dos Santos Esteves, Ana Paula
    Elias, Kevin M.
    Horowitz, Neil S.
    Braga, Antonio
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2019, 153 (02) : 277 - 285
  • [9] ACTINOMYCIN-D IN TREATMENT OF METHOTREXATE-RESISTANT MALIGNANT TROPHOBLASTIC TUMOURS
    MA, HK
    YIP, SK
    CHUN, D
    JOURNAL OF OBSTETRICS & GYNAECOLOGY OF THE BRITISH COMMONWEALTH, 1971, 78 (02): : 166 - &
  • [10] COST UTILITY ANALYSIS OF METHOTREXATE VERSUS ACTINOMYCIN-D IN LOW RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA
    Geisler, J.
    Manahan, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1328 - 1328
12345